|
The
|
|
The MedWalk trial explores the effects of a combination of a Mediterranean diet, daily exercise and social interaction on reducing cognitive decline and other dementia risk factors in older Australians.
It aims to investigate the underlying factors responsible for reducing dementia risk and the cost-effectiveness of the intervention.
Head of Neurocognitive Ageing Research at Swinburne’s Centre for Human Psychopharmacology and Chief Investigator, Professor Andrew Pipingas, says this trial is about trying to prevent the onset of dementia.
“As it’s extremely difficult to find a cure and treat those in the later stages of the disease, focusing our efforts on helping those at risk of developing dementia to stay healthy is one-way to ensure Australians stay well in future.”
It aims to investigate the underlying factors responsible for reducing dementia risk and the cost-effectiveness of the intervention.
Head of Neurocognitive Ageing Research at Swinburne’s Centre for Human Psychopharmacology and Chief Investigator, Professor Andrew Pipingas, says this trial is about trying to prevent the onset of dementia.
“As it’s extremely difficult to find a cure and treat those in the later stages of the disease, focusing our efforts on helping those at risk of developing dementia to stay healthy is one-way to ensure Australians stay well in future.”
